ECM Weekly (26 Apr 2020) - Kingsoft Cloud, WeDoctor, Akesobio, Kotak Mahindra Bank
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
Akeso Biopharma Inc (9926 HK) traded well on its Hong Kong IPO debut and closed about 50% above its IPO price. Ke Yan, CFA, FRM discussed deal dynamics and price levels in his trading note:
We are expecting more IPOs to come on the back of Akeso's strong performance giving bankers confidence to launch more deals in Hong Kong. There were news reports that Shenzhen Hepalink Pharma Co., Ltd. (002399 CH) has gotten CSRC approval for its Hong Kong IPO (A/H listing) and Peijia Medical (1740651D CH) has sought for Hong Kong approval this week and WeDoctor is looking to list in Hong Kong (from news earlier). We covered upcoming IPOs in:
- Shenzhen Hepalink (海瑞普) A+H: FY2019 Results Snippet and Valuation Update
- Peijia Medical (沛嘉医疗) Pre-IPO: Reminiscence of Venus Medtech?
- WeDoctor (微医) Pre-IPO - A More Focused Online Medical Service Provider than Ping An Good Doctor
- Ping An Good Doctor (平安好医生) - What Can We Expect from WeDoctor (微医)
However, in an unfortunate turn of events, SCMP reported that Megvii Technology (1737211D HK) may turn to the Star market in Shanghai for listing after its Hong Kong application lapsed in February.
There were also a handful of placements in Hong Kong this week. Sino Biopharmaceutical (1177 HK) struggled to hold above its deal price after its founder sold down some shares worth about US$300m. Hansoh Pharmaceutical (3692 HK), on the other hand, did way better, closed at HKD30.05 on Friday, about 12% above its deal price.
- Hansoh Pharma Placement - Good Stock but Valuation and No Lack of Cash Makes It Appear Opportunistic
- Sino Biopharm (中国生物制药) Placement - Not a Big Deal, Still a Good Company but Relatively Expensive
Other market were mostly quiet with a few placements. In Australia, Ramsay Health Care (RHC AU) raised about US$750m in its placement to enhance financial flexibility while Metcash Ltd (MTS AU) raise US$190m to shore up balance sheet and working capital needs. Whereas, in India, Kotak Mahindra Bank (KMB IN) is preparing for an equity capital raise with both primary and secondary shares. The selldown has been well anticipated while the primary raise should help strengthen. With support from index flows, the deal should trade well. Read more in:
- Kotak Placement - Early Look - Gearing up for a US$1.5bn+ Raising/Selldown, Index Flows Will Help
- Ramsay Healthcare Placement - Past Deals Have Done Well, Missed Revenue Will Be Back
- Metcash Placement - Has Done Well Of Late but We Remain Lukewarm
- Tenaga Nasional Placement - Fifth Block in as Many Years
Last but not least, another China ADR is ready to brave the U.S. market after Luckin Coffee (LK US)'s scandal. Ebang (EBANG US) filed for a US$100m IPO on Friday. Aside from that, Ke Yan, CFA, FRM continued his coverage on Kingsoft Cloud (1775017D US) with valuation and peer comparison.
Accuracy Rate:
Our overall accuracy rate is 73.4% for IPOs and 65.3% for Placements
(Performance measurement criteria is explained at the end of the note)
New IPO filings this week
- Hangzhou Tigermed (US$1bn, Hong Kong)
- Ebang International (~US$100m, U.S.)
Below is a snippet of our IPO tool showing upcoming events for the next week. The IPO tool is designed to provide readers with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the deals that we have worked on. You can access the tool here or through the tools menu.
News on Upcoming IPOs
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
- ECM Weekly (17 May 2020) -Dada Nexus, Kintor Pharma, Yeahka, Archosaur Games17 May 2020
- ECM Weekly (10 May 2020) - Kingsoft Cloud, NetEase, Central China New Life, Peijia Medical, Kintor,10 May 2020
- ECM Weekly (3 May 2020) - JD.com, Hangzhou Tigermed, Peijia Medical, Central China New Life03 May 2020
- Kingsoft Cloud (金山云) Pre-IPO: Thoughts on Peers and Valuation23 Apr 2020
- Hansoh Pharma Placement - Good Stock but Valuation and No Lack of Cash Makes It Appear Opportunistic21 Apr 2020
- ECM Weekly (19 Apr 2020) - Kingsoft Cloud, Akesobio, Shenzhen Hepalink, China Gas, Yageo19 Apr 2020